Working with TipRanks
Follow Us
Stocks
ETFs
Options
Commodities
Crypto
Currency
Pro Newsletters
Research Tools
Calendars
Economic Indicators
Calculators
Education
About Us
Working with TipRanks
Follow Us
Hyloris Pharmaceuticals SA (DE:52U)
FRANKFURT:52U
RESEARCH TOOLSreports
Holding DE:52U?
Track your performance easily
52U Stock Chart & Stats
Day’s Range€0 - €0
52-Week Range€10.80 - €13.35
Previous Close€11.4
Volume0.00
Average Volume (3M)N/A
Market Cap
€146.72M
Enterprise Value€88.79M
Total Cash (Recent Filing)€58.00M
Total Debt (Recent Filing)€66.00K
Price to Earnings (P/E)―
Beta-0.10
Next Earnings
Aug 29, 2024EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding28,000,374
10 Day Avg. Volume0
30 Day Avg. VolumeN/A
Standard DeviationN/A
R-SquaredN/A
AlphaN/A
Financial Highlights & Ratios
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)N/A
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
€18.70Price Target Upside64.04% Upside
Rating ConsensusModerate Buy
Number of Analyst Covering1
Options Prices
Currently, No data available
---
Ownership Overview
0.00%
Insiders
<0.01% Mutual Funds
<0.01% Other Institutional Investors
99.99% Public Companies and
Individual Investors
52U FAQ
What was Hyloris Pharmaceuticals SA’s price range in the past 12 months?
Hyloris Pharmaceuticals SA lowest stock price was €10.80 and its highest was €13.35 in the past 12 months.
What is Hyloris Pharmaceuticals SA’s market cap?
Currently, no data Available
When is Hyloris Pharmaceuticals SA’s upcoming earnings report date?
Hyloris Pharmaceuticals SA’s upcoming earnings report date is Aug 29, 2024 which is in 24 days.
How were Hyloris Pharmaceuticals SA’s earnings last quarter?
Hyloris Pharmaceuticals SA released its earnings results on Mar 14, 2024. The company reported -€0.312 earnings per share for the quarter, missing the consensus estimate of N/A by -€0.312.
Is Hyloris Pharmaceuticals SA overvalued?
According to Wall Street analysts Hyloris Pharmaceuticals SA’s price is currently Undervalued.
Does Hyloris Pharmaceuticals SA pay dividends?
Hyloris Pharmaceuticals SA does not currently pay dividends.
What is Hyloris Pharmaceuticals SA’s EPS estimate?
Hyloris Pharmaceuticals SA’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Hyloris Pharmaceuticals SA have?
Hyloris Pharmaceuticals SA has 28,000,374 shares outstanding.
What happened to Hyloris Pharmaceuticals SA’s price movement after its last earnings report?
Hyloris Pharmaceuticals SA reported an EPS of -€0.312 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -1.195%.
Which hedge fund is a major shareholder of Hyloris Pharmaceuticals SA?
Currently, no hedge funds are holding shares in DE:52U
---
Hyloris Pharmaceuticals SA Stock Smart Score
Company Description
Hyloris Pharmaceuticals SA
Hyloris Pharmaceuticals SA is an early-stage specialty pharmaceutical company focused on adding value to the healthcare system by reformulating pharmaceuticals. The company develops proprietary products it believes offer advantages compared to available alternatives, to address the underserved medical needs of patients, hospitals, physicians, payors and other stakeholders in the healthcare system. Its portfolio spans three areas of focus IV Cardiovascular, Other Reformulations and Established Market (high-barrier generics). It has two early commercial-stage products, Sotalol IV for the treatment of atrial fibrillation, and Maxigesic IV, a non-opioid analgesic product for the treatment of pain. It has 12 product candidates in various stages of development.
---
52U Stock 12 Month Forecast
Average Price Target
€18.70
▲(64.04% Upside)
Technical Analysis
Best Analysts Covering 52U
1 Year
1 Year Success Rate
0/2 ratings generated profit
1 Year Average Return
0.00%
reiterated a buy rating 28 days ago
Copying Christophe dombu's trades and holding each position for 1 Year would result in 0.00% of your transactions generating a profit, with an average return of 0.00% per trade.
---